The Mark Foundation for Cancer Research announced the recipients of the 2026 Emerging Leader Awards, recognizing five early-career scientists poised to make significant impacts in oncology.
Stand Up To Cancer and Cancer Research UK secured $3 million in new support for a “dream team” focused on stopping gastric cancer in its earliest stages.
Katie Coleman was appointed senior advisor for translational innovation at the Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Alex Bates was appointed director of executive communications for the Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Will Parsons was appointed as chief of the Division of Hematology-Oncology in the Department of Pediatrics at Baylor College of Medicine and director of Texas Children’s Cancer and Hematology Center, effective immediately.
American Center for Cures and BlueCloudX announced a strategic collaboration aimed at accelerating the development of cures for major diseases while dramatically reducing the time, cost, and complexity of clinical research.
Robert S. Negrin, professor of medicine at Stanford University, will serve as president of the American Society of Hematology for a year-long term through December 2026.
Joshua J. Cooper has been named executive vice president of government relations, economics, and health policy at the American College of Radiology.
The Northwell Cancer Institute opened a $1 million high-dose rate brachytherapy radiation medicine suite at the R.J. Zuckerberg Cancer Center, located near the border of Long Island and Queens.
Deborah Schrag, a gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center, was elected 2027-28 president of the American Society of Clinical Oncology.
